Mammalian target of rapamycin inhibition and alloantigen-specific regulatory T cells synergize to promote long-term graft survival in immunocompetent recipients
about
Immunotherapy with myeloid cells for tolerance inductionA systems model for immune cell interactions unravels the mechanism of inflammation in human skin.The cyclophilin-binding agent Sanglifehrin A is a dendritic cell chemokine and migration inhibitorHost-based Th2 cell therapy for prolongation of cardiac allograft viability.Mesenchymal stem cells for inducing tolerance in organ transplantationImmune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance.Cutting edge: Rapamycin augments pathogen-specific but not graft-reactive CD8+ T cell responses.How tolerogenic dendritic cells induce regulatory T cellsCD4(+)CD25(-)Nrp1(+) T cells synergize with rapamycin to prevent murine cardiac allorejection in immunocompetent recipientsRequirements for prolongation of allograft survival with regulatory T cell infusion in lymphosufficient hosts.mTOR and metabolic regulation of conventional and regulatory T cells.Generation, cryopreservation, function and in vivo persistence of ex vivo expanded cynomolgus monkey regulatory T cells.The transcription factor MITF is a critical regulator of GPNMB expression in dendritic cells.Regulatory T cells for tolerance therapy: revisiting the concept.Selective expansion of allogeneic regulatory T cells by hepatic stellate cells: role of endotoxin and implications for allograft toleranceRegulatory T cells exhibit decreased proliferation but enhanced suppression after pulsing with sirolimus.Bioinspired controlled release of CCL22 recruits regulatory T cells in vivoSolid Lipid Nanoparticles (SLNs) for Intracellular Targeting ApplicationsImpact of immunosuppressive drugs on the therapeutic efficacy of ex vivo expanded human regulatory T cells.Sequential monitoring and stability of ex vivo-expanded autologous and nonautologous regulatory T cells following infusion in nonhuman primates.Controlled release formulations of IL-2, TGF-β1 and rapamycin for the induction of regulatory T cells.Serine protease inhibitor 6 plays a critical role in protecting murine granzyme B-producing regulatory T cells.Combined administration of a mutant TGF-beta1/Fc and rapamycin promotes induction of regulatory T cells and islet allograft tolerance.Ex vivo-expanded cynomolgus macaque regulatory T cells are resistant to alemtuzumab-mediated cytotoxicity.Combining Theoretical and Experimental Techniques to Study Murine Heart Transplant Rejection.Rapamycin-conditioned donor dendritic cells differentiate CD4CD25Foxp3 T cells in vitro with TGF-beta1 for islet transplantation.T regulatory cells and the control of alloimmunity: from characterisation to clinical application.Tolerogenic dendritic cells and their potential applications.Immunologic unresponsiveness to alloantigen in vivo: a role for regulatory T cells.Rejection and regulation: a tight balance.Translating tolerogenic therapies to the clinic - where do we stand?Promoting transplantation tolerance; adoptive regulatory T cell therapy.Transplant tolerance: new insights and strategies for long-term allograft acceptance.Harnessing regulatory T cells for clinical use in transplantation: the end of the beginning.Potential and limitations of regulatory T-cell therapy in solid organ transplantation.Novel therapeutic and diagnostic management of heart transplant patients.Cell Therapy in Kidney Transplantation: Focus on Regulatory T Cells.Transplant trials with Tregs: perils and promises.Dendritic cells with TGF-β1 and IL-2 differentiate naive CD4+ T cells into alloantigen-specific and allograft protective Foxp3+ regulatory T cells.A Novel mTORC1-Dependent, Akt-Independent Pathway Differentiates the Gut Tropism of Regulatory and Conventional CD4 T Cells.
P2860
Q27687406-11F640EE-CA0F-48CD-8A6D-C8F13D199037Q33769731-5948B434-C732-468D-9C14-B6BED9CEF03BQ33869604-E6EC6AA3-F27D-4848-B0FE-87CE859A7CFEQ33895312-5A89E636-8A16-4D1F-8EE6-ABD15A64E0A7Q34391029-F05CF32A-5C60-4EFC-A06C-E2093302F8DCQ34400439-F8DFC923-A1C8-4B4B-BFB4-E731A23A4ECDQ34565248-6AD5C5DD-A252-40DA-820E-1A0CC4E4C988Q34631825-527D0B24-A8BF-4F90-B40D-5D56ABFDD7C9Q34664134-1B436A5C-0A0C-4E0A-979C-86C6A531CC18Q35044185-E50A967B-762C-4A62-B35D-2A1C8174255CQ35430711-9D554AA7-91A3-42CB-99A1-0C9A156CAA97Q35514307-4EE6CA6B-14A7-43CD-BB8E-365C0FAE67F5Q35608944-D02F7690-73BE-4132-A868-17CE3E1E33ABQ35621984-F75876A3-EEE6-4AC9-98AB-B4D699AAC117Q35893430-A6B78BEF-73DC-4D83-B6E8-79B58770BACCQ36316613-8686B62E-56C9-40C1-8E52-082A5BD1E7AAQ36379675-F659B4E6-F6C7-4166-878C-871F939B0663Q36408352-66C91D30-197B-47CA-A2E0-EA20962AFAB3Q36420758-9C64496C-F75C-4092-8260-256703941FE4Q36638732-DFA92492-7CC9-4A5D-921D-78DE712A2E43Q36998551-8AFA60B6-3BF4-46FE-85E5-F450F76BB71BQ37112525-31298315-7128-427C-AD86-995F457774D9Q37155930-2381390E-8FB9-4F24-B1FA-430D6984AABDQ37191195-3EF869DE-9B7D-498E-9432-CCB858EAD8B8Q37396882-46BC3117-BED2-475E-BB0A-897E7AAA02ECQ37716661-A601B68D-B4C3-4E77-B319-8FC713FBAD31Q37792312-FA0FAA6D-FD58-4070-90FD-B2270050880CQ37826217-24EE6CB4-FA50-4AA1-B45E-B02947243D4CQ37864694-100E4DF5-9469-461C-9436-EAD3523A5DF6Q37966922-16886FF1-2CD5-402C-93B9-8E95FEA338D5Q38039091-2DD59B76-9860-4B15-99D2-CA7572A479DDQ38097917-B70C225E-B5AD-451D-8EAB-991CC980131DQ38114067-D7430E20-C2B2-491F-A028-F5D31900160CQ38193165-FFF1491D-B335-467F-BCC1-50315C1BC40DQ38235166-1299F8A4-85FF-46C9-BA25-CA606E1559D4Q38614686-CA237A7E-F353-4EF2-A62A-E26266AB183AQ39279238-9362493C-C884-4CC6-B6FB-F72D90226E75Q39406891-F8EFB24F-8AFE-4367-A8AA-5930FC133AEFQ41208509-76762434-A41B-40E0-933C-526371F6E810Q41891740-E2F59289-BAE2-4986-BA1E-C90324890E42
P2860
Mammalian target of rapamycin inhibition and alloantigen-specific regulatory T cells synergize to promote long-term graft survival in immunocompetent recipients
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Mammalian target of rapamycin ...... in immunocompetent recipients
@ast
Mammalian target of rapamycin ...... in immunocompetent recipients
@en
Mammalian target of rapamycin ...... in immunocompetent recipients
@nl
type
label
Mammalian target of rapamycin ...... in immunocompetent recipients
@ast
Mammalian target of rapamycin ...... in immunocompetent recipients
@en
Mammalian target of rapamycin ...... in immunocompetent recipients
@nl
prefLabel
Mammalian target of rapamycin ...... in immunocompetent recipients
@ast
Mammalian target of rapamycin ...... in immunocompetent recipients
@en
Mammalian target of rapamycin ...... in immunocompetent recipients
@nl
P2093
P2860
P356
P1476
Mammalian target of rapamycin ...... in immunocompetent recipients
@en
P2093
Angus W Thomson
Benjamin M Matta
Giorgio Raimondi
Mahesh Pillai
Natasha Corbitt
Tina L Sumpter
Yoram Vodovotz
Zhiliang Wang
P2860
P304
P356
10.4049/JIMMUNOL.0900936
P407
P577
2009-12-09T00:00:00Z